Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study

Abstract Genetic testing for BRCA1 and BRCA2 is crucial in diagnosing hereditary breast and ovarian cancer syndromes and has increased with the development of multigene panel tests. However, results classified as variants of uncertain significance (VUS) present challenges to clinicians in attempting...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Joo Heung Kim, Sunggyun Park, Hyung Seok Park, Ji Soo Park, Seung-Tae Lee, Sung-Won Kim, Jong Won Lee, Min Hyuk Lee, Sue K. Park, Woo-Chul Noh, Doo Ho Choi, Wonshik Han, Sung Hoo Jung
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/b5010b431758434caee1abe0f2f5c7e7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b5010b431758434caee1abe0f2f5c7e7
record_format	dspace
spelling	oai:doaj.org-article:b5010b431758434caee1abe0f2f5c7e72021-12-02T17:33:00ZAnalysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study10.1038/s41598-021-87792-w2045-2322https://doaj.org/article/b5010b431758434caee1abe0f2f5c7e72021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87792-whttps://doaj.org/toc/2045-2322Abstract Genetic testing for BRCA1 and BRCA2 is crucial in diagnosing hereditary breast and ovarian cancer syndromes and has increased with the development of multigene panel tests. However, results classified as variants of uncertain significance (VUS) present challenges to clinicians in attempting to choose an appropriate management plans. We reviewed a total of 676 breast cancer patients included in the Korean Hereditary Breast Cancer (KOHBRA) study with a VUS on BRCA mutation tests between November 2007 and April 2013. These results were compared to the ClinVar database. We calculated the incidence and odds ratios for these variants using the Korean Reference Genome Database. A total of 58 and 91 distinct VUS in BRCA1 and BRCA2 were identified in the KOHBRA study (comprising 278 and 453 patients, respectively). A total of 27 variants in the KOHBRA study were not registered in the Single Nucleotide Polymorphism database. Among BRCA1 VUSs, 20 were reclassified as benign or likely benign, four were reclassified as pathogenic or likely pathogenic, and eight remained as VUSs according to the ClinVar database. Of the BRCA2 VUSs, 25 were reclassified as benign or likely benign, two were reclassified as pathogenic or likely pathogenic, and 33 remained as VUS according to the ClinVar database. There were 12 variants with conflicting interpretations of pathogenicity for BRCA1 and 18 for BRCA2. Among them, p.Leu1780Pro showed a particularly high odds ratio. Six pathogenic variants and one conflicting variant identified using ClinVar could be reclassified as pathogenic variants in this study. Using updated ClinVar information and calculating odds ratios can be helpful when reclassifying VUSs in BRCA1/2.Joo Heung KimSunggyun ParkHyung Seok ParkJi Soo ParkSeung-Tae LeeSung-Won KimJong Won LeeMin Hyuk LeeSue K. ParkWoo-Chul NohDoo Ho ChoiWonshik HanSung Hoo JungNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Joo Heung Kim Sunggyun Park Hyung Seok Park Ji Soo Park Seung-Tae Lee Sung-Won Kim Jong Won Lee Min Hyuk Lee Sue K. Park Woo-Chul Noh Doo Ho Choi Wonshik Han Sung Hoo Jung Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
description	Abstract Genetic testing for BRCA1 and BRCA2 is crucial in diagnosing hereditary breast and ovarian cancer syndromes and has increased with the development of multigene panel tests. However, results classified as variants of uncertain significance (VUS) present challenges to clinicians in attempting to choose an appropriate management plans. We reviewed a total of 676 breast cancer patients included in the Korean Hereditary Breast Cancer (KOHBRA) study with a VUS on BRCA mutation tests between November 2007 and April 2013. These results were compared to the ClinVar database. We calculated the incidence and odds ratios for these variants using the Korean Reference Genome Database. A total of 58 and 91 distinct VUS in BRCA1 and BRCA2 were identified in the KOHBRA study (comprising 278 and 453 patients, respectively). A total of 27 variants in the KOHBRA study were not registered in the Single Nucleotide Polymorphism database. Among BRCA1 VUSs, 20 were reclassified as benign or likely benign, four were reclassified as pathogenic or likely pathogenic, and eight remained as VUSs according to the ClinVar database. Of the BRCA2 VUSs, 25 were reclassified as benign or likely benign, two were reclassified as pathogenic or likely pathogenic, and 33 remained as VUS according to the ClinVar database. There were 12 variants with conflicting interpretations of pathogenicity for BRCA1 and 18 for BRCA2. Among them, p.Leu1780Pro showed a particularly high odds ratio. Six pathogenic variants and one conflicting variant identified using ClinVar could be reclassified as pathogenic variants in this study. Using updated ClinVar information and calculating odds ratios can be helpful when reclassifying VUSs in BRCA1/2.
format	article
author	Joo Heung Kim Sunggyun Park Hyung Seok Park Ji Soo Park Seung-Tae Lee Sung-Won Kim Jong Won Lee Min Hyuk Lee Sue K. Park Woo-Chul Noh Doo Ho Choi Wonshik Han Sung Hoo Jung
author_facet	Joo Heung Kim Sunggyun Park Hyung Seok Park Ji Soo Park Seung-Tae Lee Sung-Won Kim Jong Won Lee Min Hyuk Lee Sue K. Park Woo-Chul Noh Doo Ho Choi Wonshik Han Sung Hoo Jung
author_sort	Joo Heung Kim
title	Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
title_short	Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
title_full	Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
title_fullStr	Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
title_full_unstemmed	Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
title_sort	analysis of brca1/2 variants of unknown significance in the prospective korean hereditary breast cancer study
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/b5010b431758434caee1abe0f2f5c7e7
work_keys_str_mv	AT jooheungkim analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT sunggyunpark analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT hyungseokpark analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT jisoopark analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT seungtaelee analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT sungwonkim analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT jongwonlee analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT minhyuklee analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT suekpark analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT woochulnoh analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT doohochoi analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT wonshikhan analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy AT sunghoojung analysisofbrca12variantsofunknownsignificanceintheprospectivekoreanhereditarybreastcancerstudy
_version_	1718380084302184448

Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study

Ejemplares similares